FDA begins a probe following the disclosure of Johnson & Johnson (NYSE:JNJ) on Wednesday that one of the active ingredients in a batch of COVID-19 vaccines at its contractor’s premises does not meet quality criteria. Scraps a batch of COVID-19 vaccine According to...
Johnson and Johnson (NYSE:JNJ) has announced that the European Commission has approved a supply agreement on behalf of EU members states for the supply of 400 million doses of COVID-19 vaccine. EC to purchase 400 million doses of JNJ’s vaccine According to the Advance...
